Inostics' Acquisition

Inostics was acquired by Sysmex on September 25, 2013.

Inostics is a diagnostics service company providing molecular testing for individualized cancer patient management and drug development. The core competency of Inostics is centered around the detectio…

Articles about Inostics' Acquisition: